|
|
Wnt antagonist genes in kidney tumor progression and metastasis
|
1R01CA130860-01
|
$600,893
|
$600,893
|
DAHIYA, RAJVIR
|
NORTHERN CALIFORNIA INSTITUTE RES & EDUC
|
|
|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
Z01 BC 011050
|
$32,786
|
$32,787
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
|
VHL Ubiquitin Ligase Activity and Oxygen regulated gene expression
|
5R01CA125930-02
|
$225,720
|
$225,720
|
GNARRA, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
VHL and FGFR signaling in angiogenesis
|
5R01CA109860-05
|
$283,792
|
$96,489
|
HSU, TIEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VHL
|
Z01 CP005803-08290
|
$4,523
|
$1,809
|
Goldstein, Alisa
|
DCEG (NCI)
|
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
Z01 CP010183-00580
|
$179,292
|
$17,929
|
Anderson, William
|
DCEG (NCI)
|
|
|
Venous Window Access Catheter For Hemodialysis
|
1R44CA139608-01A1
|
$124,200
|
$124,200
|
Johnson, Steven
|
VITAL ACCESS, INC.
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$1,199
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$95,910
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$17,588
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-09
|
$220,657
|
$22,066
|
SCARDINO, PETER
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
UMB/DFHCC Comprehensive Cancer Partnership Program
|
5U56CA118635-04
|
$429,888
|
$42,989
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
|
Tumor models for the study of inflammation and oncogenesis
|
Z01 BC 010893
|
$203,062
|
$203,063
|
Wiltrout, Robert
|
CCR (NCI)
|
|
|
Tumor Induced Dysregulation of T Cell Immunity
|
5R01CA116255-03
|
$261,665
|
$261,665
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Tumor Gangliosides and TNF Synergize for T Cell Death
|
5R01CA111917-04
|
$257,865
|
$257,865
|
TANNENBAUM, CHARLES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Transplant Models
|
Z01 BC 010957
|
$530,539
|
$53,054
|
Gress, Ronald
|
CCR (NCI)
|
|
|
TRAIL Mediated Apoptosis in Renal Cell Carcinoma
|
5K08CA113452-04
|
$127,794
|
$127,794
|
CLARK, PETER
|
VANDERBILT UNIVERSITY
|
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-25
|
$721,858
|
$7,219
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
|
Therapeutic Modulation of COX-2-induced Immunosuppression in Metastatic RCC
|
5R21CA123854-02
|
$293,550
|
$293,550
|
RINI, BRIAN
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
The role of Toll-like receptor 3 in overcoming cancer immunoediting
|
5K22CA122828-02
|
$162,047
|
$16,205
|
Bell, Jessica
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
The role of selenoproteins in the etiology of cancer
|
5R01CA115616-04
|
$223,970
|
$111,985
|
MOOS, PHILIP
|
UNIVERSITY OF UTAH
|
|
|
The Role of Fgf Signaling in Vertebrate Development
|
Z01 BC 010338
|
$278,081
|
$55,616
|
Lewandoski, Mark
|
CCR (NCI)
|
|
|
The role of angiopoietins in Wilms tumor
|
5K08CA107077-04
|
$134,946
|
$134,946
|
HUANG, JIANZHONG
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S1
|
$91,948
|
$919
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S2
|
$49,383
|
$494
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-15S3
|
$83,152
|
$832
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-15
|
$5,084,061
|
$50,841
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The p270 SWI/SNF subunit as a potential Wilms' tumor susceptibility gene
|
1R21CA127696-01A1
|
$175,500
|
$175,500
|
Moran, Elizabeth
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-33S1
|
$89,606
|
$896
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
The Ohio State University Comprehensive Cancer Center
|
5P30CA016058-33
|
$3,753,703
|
$37,537
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
The MiT Transcription Factor in Pediatric Malignancies
|
5R01CA102309-05
|
$299,147
|
$149,574
|
FISHER, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
|
The Brooklyn Minority-Based Community Clinical Oncology*
|
5U10CA114671-02
|
$554,189
|
$5,542
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
|
TGF Beta receptor biology in human renal cell carcinoma
|
5R01CA104505-05
|
$228,938
|
$228,938
|
COPLAND, JOHN
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
7R01CA077091-05
|
$338,540
|
$67,708
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
|
Technology/Map Endothelial Targets/Human Renal Tumors
|
5R33CA118602-03
|
$681,704
|
$681,704
|
SCHNITZER, JAN
|
SIDNEY KIMMEL CANCER CENTER
|
|
|
Targeting Tumor Angiogenesis with SAHA and Bevacizumab in Kidney Cancer
|
5R21CA121590-02
|
$249,280
|
$249,280
|
Pili, Roberto
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Targeting Tumor Angiogenesis with G-Quadruplex Binders
|
3R01CA109069-03S1
|
$51,840
|
$25,920
|
SUN, DAEKYU
|
UNIVERSITY OF ARIZONA
|
|
|
Targeting Tumor Angiogenesis with G-Quadruplex Binders
|
5R01CA109069-03
|
$260,253
|
$130,127
|
SUN, DAEKYU
|
UNIVERSITY OF ARIZONA
|
|
|
Targeting Novel T Cell Antigens on Renal Cell Carcinoma
|
5K08CA121912-03
|
$134,460
|
$134,460
|
TYKODI, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Targeting HIF-1alpha in renal cell carcinoma: the role of HDAC inhibitors
|
1R01CA135321-01A1
|
$337,432
|
$337,432
|
Pili, Roberto
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Tailored Algorithms for Non-Contrast Computed Tomography Using Sinogram Restorati
|
1R01CA134680-01
|
$270,049
|
$135,025
|
LA RIVIERE, PATRICK
|
UNIVERSITY OF CHICAGO
|
|
|
SWOG Institutional Grant
|
5U10CA073590-12
|
$1
|
$0
|
SONDAK, VERNON
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Swedish CER occupational study
|
Z01 CP010183-02050
|
$10,053
|
$2,011
|
Anderson, William
|
DCEG (NCI)
|
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$140,169
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Surgical Pathology
|
Z01 SC 000853
|
$252,402
|
$151,442
|
Merino, Maria
|
CCR (NCI)
|
|
|
Support for Human Specimen Banking in NCI-Supported Cancer Clinical Trials
|
5U24CA114766-04
|
$993,896
|
$198,779
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
|
SUNY Downstate Medical Center Minority-Based Community Clinical Oncology Program
|
3U10CA114671-02S1
|
$100,000
|
$1,000
|
Solomon, William
|
SUNY DOWNSTATE MEDICAL CENTER
|
|
|
Study of Hereditary Renal Syndromes
|
Z01 BC 010696
|
$252,402
|
$252,403
|
Merino, Maria
|
CCR (NCI)
|
|
|
Studies of Childhood Solid Tumors
|
5P01CA023099-30
|
$2,219,539
|
$221,954
|
HOUGHTON, PETER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Stroger Hospital of Cook County, Department of Surgery,*
|
3U10CA095867-07S1
|
$99,993
|
$1,000
|
ZAREN, HOWARD
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
Total relevant funding to Kidney Disease for this search: $43,431,683
|
